Взаимосвязь питания и гериатрических синдромов у пожилых пациентов с сахарным диабетом 2 типа

Одной из актуальных задач современной медицины, ассоциированных с прогрессирующим старением населения, является формирование стратегии ведения пожилых пациентов с сахарным диабетом 2 типа (СД2), включающей междисциплинарный подход с учетом комплексной гериатрической оценки, оптимизацию гликемического контроля, персонализированные фармакологическую терапию и диетотерапию. Патогенез СД2, старческой астении (СА) и когнитивной дисфункции тесно взаимосвязаны в контексте старения. Инсулинорезистентность, атеросклероз, хроническое воспаление, окислительный стресс и митохондриальная дисфункция неотъемлемо вовлечены в механизм развития патогенетических звеньев СА, когнитивных нарушений и СД2. Диетические рекомендации, направленные на адекватное потребление макро-/микронутриентов, способствуют предотвращению или замедлению развития возраст ассоциированных заболеваний, помогут улучшить качество и увеличить продолжительность жизни у пожилых людей с СД2. В данном обзоре литературы проведен анализ современных данных о важности правильного питания для гликемического контроля, профилактики СА, саркопении и деменции у больных СД2 пожилого возраста.

гериатрические синдромы, сахарный диабет 2 типа, старческая астения, саркопения, когнитивные нарушения, макронутриенты, микронутриенты, рациональное питание

1. WHO. Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health (Accessed: 26 march 2022)

2. Lazebnik L.B., Konev Yu.V., Efremov L.I. The main problem of geriatrics: the multiplicity of diseases in elderly patients. Clinical gerontology. 2019;25(1-2):4-9. (In Russ.) doi: 10.26347/1607-2499201901-02004-009.@@ Лазебник Л.Б., Конев Ю.В., Ефремов Л.И. Основная проблема гериатрии - множественность болезней у пожилого больного. Клиническая геронтология. 2019;25(1-2):4-9. doi: 10.26347/1607-2499201901-02004-009.

3. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Sazonova D.V., Mokrysheva N.G. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010-2022. Diabetes mellitus. 2023;26(2):104-123. (In Russ.) doi: 10.14341/DM13035.@@ Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Сазонова Д.В., Мокрышева Н.Г. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010-2022 гг. Сахарный диабет. 2023;26(2):104-123. doi: 10.14341/DM13035.

4. Zhang J., Yang J., Liu L. et al. Significant abnormal glycemic variability increased the risk for arrhythmias in elderly type 2 diabetic patients. BMC Endocr. Disord. 2021;21:83. doi: 10.1186/s12902-021-00753-2.

5. Xu W.L., von Strauss E., Qiu C.X. et al. Uncontrolled diabetes increases the risk of Alzheimer’s disease: A pop-ulation-based cohort study. Diabetologia. 2009;52:1031-1039. doi: 10.1007/s00125-009-1323-x.

6. Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. Seventy-fourth world health assembly. Available at: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_R4-en.pdf (Accessed: 05.02.2025)

7. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Clinical guidelines on frailty.Russian Journal of Geriatric Medicine. 2020;(1):11-46. (In Russ.) doi: 10.37586/2686-8636-1-2020-11-46.@@ Ткачева О.Н., Котовская Ю.В., Рунихина Н.К. и др. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020;(1):11-46. doi: 10.37586/2686-8636-1-2020-11-46.

8. Gómez-Gómez M.E., Zapico S.C. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions.Int J Mol Sci. 2019 Jun 11;20(11):2842. doi: 10.3390/ijms20112842.

9. Kurmaev D.P., Bulgakova S.V., Treneva E.V. et al. Physical training in a comprehensive program of prevention and treatment of sarcopenia in geriatric patients. Experimental and clinical gastroenterology. 2024;8(228): 226-241. (In Russ.) doi: 10.31146/1682-8658-ecg-228-8-226-241.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В. и др. Физические тренировки в комплексной программе профилактики и лечения саркопении у гериатрических пациентов. Экспериментальная и клиническая гастроэнтерология. 2024;8(228):226-241. doi: 10.31146/1682-8658-ecg-228-8-226-241.

10. Kurmaev D.P., Bulgakova S.V., Treneva E.V. et al. Nutritional support in a comprehensive program of prevention and treatment of sarcopenia.Russian Journal of Geriatric Medicine. 2023;(1):29-38. (In Russ.) doi: 10.37586/2686-8636-1-2023-29-38.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В. и др. Нутритивная поддержка в комплексной программе профилактики и лечения саркопении. Российский журнал гериатрической медицины. 2023;(1):29-38. doi: 10.37586/2686-8636-1-2023-29-38.

11. Fried L.P., Tangen C.M., Walston J. et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3): M146-56. doi: 110.1093/gerona/56.3.m146.

12. Chhetri J.K., Zheng Z., Xu X. et al. The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr. 2017;17(1):47. doi: 10.1186/s12877-017-0439-y.

13. Jang H.C. Sarcopenia, Frailty, and Diabetes in Older Adults. Diabetes Metab J. 2016;40(3):182-9. doi: 10.4093/dmj.2016.40.3.182.

14. Massimino E., Izzo A., Riccardi G. et al. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells. 2021;10(8):1958. doi: 10.3390/cells10081958.

15. Shirolapov I.V., Kurmaev D.P., Bulgakova S.V. et al. Cognitive impairment, dementia and sarcopenia in geriatric patients - is there a relationship? Experimental and clinical gastroenterology. 2024;(8):181-195. (In Russ.) doi: 10.31146/1682-8658-ecg-228-8-181-195.@@ Широлапов И.В., Курмаев Д.П., Булгакова С.В. и др. Когнитивные нарушения, деменция и саркопения у гериатрических пациентов - есть ли взаимосвязь? Экспериментальная и клиническая гастроэнтерология. 2024;(8):181-195. doi: 10.31146/1682-8658-ecg-228-8-181-195.

16. Cruz-Jentoft A.J., Bahat G., Bauer J. et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi: 10.1093/ageing/afz046.

17. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. doi: 10.1046/j.1532-5415.2002.50216.x.

18. Bulgakova S.V., Kurmaev D.P., Treneva E.V. Diagnostics of the body composition of an elderly person to assess the prognosis of his health. Experimental and clinical gastroenterology. 2024;2(222):89-100. (In Russ.) doi: 10.31146/1682-8658-ecg-222-2-89-100.@@ Булгакова С.В., Курмаев Д.П., Тренева Е.В. Диагностика композиционного состава тела пожилого человека для оценки прогноза состояния его здоровья. Экспериментальная и клиническая гастроэнтерология. 2024;2(222):89-100. doi: 10.31146/1682-8658-ecg-222-2-89-100.

19. Cruz-Jentoft A.J., Sayer A.A. Sarcopenia. Lancet. 2019;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9.

20. Kurmaev D.P., Bulgakova S.V., Treneva E.V. Insulin resistance, type 2 diabetes mellitus and sarcopenia. Experimental and Clinical Gastroenterology. 2024;(2):141-148. (In Russ.) doi: 10.31146/1682-8658-ecg-222-2-141-148.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В. Инсулинорезистентность, сахарный диабет 2 типа и саркопения. Экспериментальная и клиническая гастроэнтерология. 2024;(2):141-148. doi: 10.31146/1682-8658-ecg-222-2-141-148.

21. Xue M., Xu W., Ou Y.N. et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019; 55:100944. doi: 10.1016/j.arr.2019.100944.

22. Palta P., Schneider A.L., Biessels G.J. et al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20(3):278-91. doi: 10.1017/S1355617713001483.

23. Saedi E., Gheini M.R., Faiz F. et al. Diabetes mellitus and cognitive impairments. World J Diabetes. 2016 Sep 15;7(17):412-22. doi: 10.4239/wjd.v7.i17.412.

24. McIntosh E.C., Nation D.A. Alzheimer’s Disease Neuroimaging Initiative. Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer’s Disease. Diabetes Care. 2019;42(5):972-979. doi: 10.2337/dc18-1399.

25. Mallorquí-Bagué N., Lozano-Madrid M., Toledo E. et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. 2018;8(1):16128. doi: 10.1038/s41598-018-33843-8.

26. Xue M., Xu W., Ou Y.N. et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944. doi: 10.1016/j.arr.2019.100944.

27. Mitnitski A., Fallah N., Rockwood M.R. et al. Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging. 2011;15(10):863-7. doi: 10.1007/s12603-011-0066-9.

28. Kojima G., Taniguchi Y., Iliffe S. Frailty as a Predictor of Alzheimer Disease, Vascular Dementia and All Dementia Among Community-Dwelling Older People: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2016;17(10):881-8. doi: 10.1016/j.jamda.2016.05.013.

29. Liu J., Zhu Y., Tan J.K. et al. Factors Associated with Frailty in Older Adults in Community and Nursing Home Settings: A Systematic Review with a Meta-Analysis. J. Clin. Med. 2024; 13(8):2382. doi: 10.3390/jcm13082382.

30. Thein F.S., Li Y., Nyunt M.S.Z. et al. Physical frailty and cognitive impairment is associated with diabetes and adversely impact functional status and mortality. Postgrad Med. 2018;130(6):561-567. doi: 10.1080/00325481.2018.1491779.

31. Arai H., Kozaki K., Kuzuya M. et al. Chapter 2 Frailty concepts. Geriatr Gerontol Int. 2020;20 Suppl 1:14-19. doi: 10.1111/ggi.13831.

32. Dvoretskiy S., Lieblein-Boff J.C., Jonnalagadda S. et al. Exploring the Association between Vascular Dysfunction and Skeletal Muscle Mass, Strength and Function in Healthy Adults: A Systematic Review. Nutrients. 2020 Mar 7;12(3):715. doi: 10.3390/nu12030715.

33. Bulgakova S.V., Chetverikova I.S., Treneva E.V., Kurmaev D.P. Senior asthenia and type 2 diabetes: two related conditions? Clinical gerontology. 2022;28(3-4):60-67. (In Russ.) doi: 10.26347/1607-2499202203-04060-067.@@ Булгакова С.В., Четверикова И.С., Тренева Е.В., Курмаев Д.П. Старческая астения и сахарный диабет типа 2: два взаимосвязанных состояния? Клиническая геронтология. 2022;28(3-4):60-67. doi: 10.26347/1607-2499202203-04060-067 10.

34. Volkert D., Beck A.M., Cederholm Т. et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clinical Nutrition. 2019;38:10-47. doi: 10.1016/j.clnu.2018.05.024.

35. Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus. Geriatr Gerontol Int. 2016;16(3):293-9. doi: 10.1111/ggi.12688.

36. Yoshimura Y., Kamada C., Takahashi K. et al. Japanese Elderly Diabetes Intervention Trial Study Group. Relations of nutritional intake to age, sex and body mass index in Japanese elderly patients with type 2 diabetes: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12 Suppl 1:29-40. doi: 10.1111/j.1447-0594.2011.00810.x.

37. Omura T., Tamura Y., Yamaoka T. et al. Japanese Elderly Diabetes Intervention Trial Research Group. Assessing the association between optimal energy intake and all-cause mortality in older patients with diabetes mellitus using the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2020;20(1):59-65. doi: 10.1111/ggi.13820.

38. Nakamura K., Yoshida D., Honda T. et al. Prevalence and Mortality of Sarcopenia in a Community-dwelling Older Japanese Population: The Hisayama Study. J Epidemiol. 2021;31(5):320-327. doi: 10.2188/jea.JE20190289.

39. Park J.M., Lee J., Kim Y. et al. Calorie Intake and Cognitive Function in the Elderly: Data from the Korean Frailty and Aging Cohort Study (KFACS). J Nutr Health Aging. 2019;23(10):930-936. doi: 10.1007/s12603-019-1249-z.

40. Kurmaev D.P., Bulgakova S.V., Treneva E.V., Kosareva O.V., Dolgikh Yu.A., Sharonova L.A., Chetverikova I.S. Nutritional support in a comprehensive program of prevention and treatment of sarcopenia.Russian Journal of Geriatric Medicine. 2023;(1):29-38. (In Russ.) doi: 10.37586/2686-8636-1-2023-29-38.@@ Курмаев Д.П., Булгакова С.В., Тренева Е.В., Косарева О.В., Долгих Ю.А., Шаронова Л.А., Четверикова И.С. Нутритивная поддержка в комплексной программе профилактики и лечения саркопении. Российский журнал гериатрической медицины. 2023;(1):29-38. doi: 10.37586/2686-8636-1-2023-29-38.

41. Verlaan S., Ligthart-Melis G.C., Wijers S.L.J. et al. High Prevalence of Physical Frailty Among Community-Dwelling Malnourished Older Adults-A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2017;18(5):374-382. doi: 10.1016/j.jamda.2016.12.074.

42. Isanejad M., Sirola J., Rikkonen T. Higher protein intake is associated with a lower likelihood of frailty among older women, Kuopio OSTPRE-Fracture Prevention Study. Kuopio OSTPRE-Fracture Prevention Study. Eur J Nutr. 2020;59:1181-1189. doi: 10.1007/s00394-019-01978-7.

43. Coelho-Júnior H.J., Milano-Teixeira L., Rodrigues B. et al. Relative Protein Intake and Physical Function in Older Adults: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients. 2018;10:1330. doi: 10.3390/nu10091330.

44. Houston D.K., Nicklas B.J., Ding J. et al. Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr. 2008;87(1):150-5. doi: 10.1093/ajcn/87.1.150.

45. Tieland M., Franssen R., Dullemeijer C. et al. The Impact of Dietary Protein or Amino Acid Supplementation on Muscle Mass and Strength in Elderly People: Individual Participant Data and Meta-Analysis of RCT’s. J Nutr Health Aging. 2017;21(9):994-1001. doi: 10.1007/s12603-017-0896-1.

46. Hanach N.I., McCullough F., Avery A. The Impact of Dairy Protein Intake on Muscle Mass, Muscle Strength, and Physical Performance in Middle-Aged to Older Adults with or without Existing Sarcopenia: A Systematic Review and Meta-Analysis. Adv Nutr. 2019;10(1):59-69. doi: 10.1093/advances/nmy065.

47. Hanach N.I., McCullough F., Avery A. The Impact of Dairy Protein Intake on Muscle Mass, Muscle Strength, and Physical Performance in Middle-Aged to Older Adults with or without Existing Sarcopenia: A Systematic Review and Meta-Analysis. Adv Nutr. 2019;10(1):59-69 doi: 10.1093/ajcn/87.1.150.

48. Muscariello E., Nasti G., Siervo M. et al. Dietary protein intake in sarcopenic obese older women. Clin Interv Aging. 2016;11:133-40. doi: 10.2147/CIA.S96017.

49. Yamaoka T., Araki A., Tamura Y. et al. Association between Low Protein Intake and Mortality in Patients with Type 2 Diabetes. Nutrients. 2020;12(6):1629. doi: 10.3390/nu12061629.

50. Zhu H.G., Jiang Z.S., Gong P.Y. et al. Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials. Lipids Health Dis. 2018;17(1):141. doi: 10.1186/s12944-018-0791-8.

51. Bulgakova S.V., Bashinskya S.A., Zakharova N.O., Treneva E.V., Nikolaeva A.V. Vitamin D: role in the development of obesity, insulin resistance, type 2 diabetes mellitus in the elderly. Clinical gerontology. 2021;27(9-10):16-22. (in Russ.) doi: 10.26347/1607-2499202109-10016-022.@@ Булгакова СВ, Башинская СА, Захарова НО. и др. Витамин D: роль в развитии ожирения, инсулинорезистентности, сахарного диабета типа 2 у лиц пожилого и старческого возраста. Клиническая геронтология. 2021;27(9-10):16-22. doi: 10.26347/1607-2499202109-10016-022.

52. Wintermeyer E., Ihle C., Ehnert S. et al. Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients. 2016;8(6):319. doi: 10.3390/nu8060319.

53. Bo Y., Liu C., Ji Z. et al. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in sarcopenic older adults: A double-blind randomized controlled trial. Clin. Nutr. 2019;38:159-164. doi: 10.1016/j.clnu.2017.12.020.

54. Byrn M.A., Adams W., Penckofer S. et al. Vitamin D Supplementation and Cognition in People with Type 2 Diabetes: A Randomized Control Trial. J Diabetes Res. 2019;2019:5696391. doi: 10.1155/2019/5696391.

55. Kazemian E., Pourali A., Sedaghat F. et al. Effect of supplemental vitamin D3 on bone mineral density: a systematic review and meta-analysis. Nutr. Rev. 2023;81:511-530. doi: 10.1093/nutrit/nuac068.

56. Wang N., Chen Y., Ji J. et al. The relationship between serum vitamin D and fracture risk in the elderly: a meta-analysis. J Orthop Surg Res. 2020;15(1):81. doi: 10.1186/s13018-020-01603-y.

57. Cheng S.H., Chen K.H., Chen C. et al. The Optimal Strategy of Vitamin D for Sarcopenia: A Network Meta-Analysis of Randomized Controlled Trials. Nutrients 2021;13:3589. doi: 10.3390/nu13103589.

58. Vergatti A., Abate V., Zarrella A.F. et al. 25-Hydroxy-Vitamin D and Risk of Recurrent Stroke: A Dose Response Meta-Analysis. Nutrients. 2023;15(3):512. doi: 10.3390/nu15030512.

59. Milajerdi A., Ostadmohammadi V., Amirjani S. et al. The effects of vitamin D treatment on glycemic control, serum lipid profiles, and C-reactive protein in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.Int Urol Nephrol. 2019;51(9):1567-1580. doi: 10.1007/s11255-019-02236-9.

60. Balboa-Castillo T., Struijk E.A., Lopez-Garcia E. et al. Low vitamin intake is associated with risk of frailty in older adults. Age Ageing. 2018;47(6):872-879. doi: 10.1093/ageing/afy105.

61. Asbaghi O., Nazarian B., Yousefi M. et al. Effect of vitamin E intake on glycemic control and insulin resistance in diabetic patients: an updated systematic review and meta-analysis of randomized controlled trials. Nutr. J. 2023;22:10. doi: 10.1186/s12937-023-00840-1.

62. Lind M., Lauritzen L., Kristensen M. et al. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials. Am.J. Clin. Nutr. 2019;109:29-42. doi: 10.1093/ajcn/nqy234.

63. Chen L., Li Q., Fang X. et al. Dietary Intake of Homocysteine Metabolism-Related B-Vitamins and the Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies. Adv. Nutr. 2020;11:1510-1528. doi: 10.1093/advances/nmaa061.

64. Cheng P., Wang L., Ning S. et al. Vitamin E intake and risk of stroke: a meta-analysis. Br J Nutr. 2018;120(10):1181-1188. doi: 10.1017/S0007114518002647.

65. Gil Martínez V., Avedillo Salas A., Santander Ballestín S. Vitamin Supplementation and Dementia: A Systematic Review. Nutrients. 2022;14:1033. doi: 10.3390/nu14051033.

66. Ma M.L., Ma Z.J., He Y.L. et al. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Front. Public Health. 2022;10:979649. doi: 10.3389/fpubh.2022.979649.

67. Bhatt D.L., Steg P.G., Miller M. et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N. Engl. J. Med. 2019;380:11-22. doi: 10.1056/NEJMoa1812792.

68. Jayanama К., Theou О., Godin J. et al. Association of fatty acid consumption with frailty and mortality among middle-aged and older adults. Nutrition. 2020;70:110610. doi: 10.1016/j.nut.2019.110610.

69. Brainard J.S., Jimoh O.F., Deane K.H.O. et al. PUFAH group. Omega-3, Omega-6, and Polyunsaturated Fat for Cognition: Systematic Review and Meta-analysis of Randomized Trials. J Am Med Dir Assoc.2020;21(10):1439-1450.e21. doi: 10.1016/j.jamda.2020.02.022.

70. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023, 66, 965-985. doi: 10.1007/s00125-023-05894-8.

71. Kojima G., Avgerinou K., Iliffe S. et al. Adherence to Mediterranean Diet Reduces Incident Frailty Risk: Systematic Review and Meta-Analysis. J. Am. Geriatr. Soc. 2018;66:783-788. doi: 10.1111/jgs.15251.

72. Rashidi Pour Fard N., Amirabdollahian F., Haghighatdoost F. Dietary patterns and frailty: a systematic review and meta-analysis. Nutr Rev. 2019;77(7):498-513. doi: 10.1093/nutrit/nuz007.

73. Adopting a healthy lifestyle helps reduce the risk of dementia. WHO recommendations. 2019. Available at: https://www.who.int/ru/news/item/14-05-2019-adopting-a-healthy-lifestyle-helps-reduce-the-risk-of-dementia (Accessed: 05.02.2025.)